LIKMETA, M.; SHKOZA, A.; ZGURI, L.; KRAJA, B. CHRONIC HEPATITIS C WITH SIGNIFICANT MORBIDITY AND END-ORGAN DAMAGE DEVELOPMENT DURING PEG-INTERFERON ALPHA-2A/RIBAVIRIN THERAPY. European Scientific Journal, ESJ, v. 11, n. 18, 29 Jun. 2015.